Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC ...

Australian biotech investors received a brutal reminder of the sector’s binary risk on Friday, as Immutep Ltd (ASX:IMM) ...

Candel Therapeutics Inc (NASDAQ:CADL) is advancing plans to bring its lead cancer immunotherapy toward potential ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...

Cancer remains one of the most formidable challenges in modern medicine — but it is also one of the most dynamic frontiers of pharmaceutical innovation. Over the past decade, oncology has become the ...

Doctors have a new emerging weapon in the fight against cancerous tumors: ultrasound. After a five-year study by the ...

Hoover Institution Senior Fellow Victor Davis Hanson on Wednesday shared an update about his health after doctors removed part of his lung while treating a rare form of cancer. Hanson announced in ...

Initiated US Phase 1/2a study of DLL3-targeting 212Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed with strategic partner Orano Med; initial data ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...

Piccioli is now raising awareness about colorectal cancer and urging patients to explore transplant options if the disease spreads to the liver A woman with stage 4 cancer received a liver from her ...

Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.